News + Filings Holdings
|
|
Soleus Capital Management, L.P.
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
| Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
|
UNITED THERAPEUTICS Corp
| UTHR | Common | 242,735 | 106,500 | 53,583,751,000 | 23,072,560,000 | 5.96 | 0.52 |
Hist
| 06/30/2023 |
|
SURMODICS INC
| SRDX | COM | 1,336,838 | 444,160 | 41,856,398,000 | 21,521,193,000 | 4.65 | 9.46 |
Hist
| 06/30/2023 |
|
Organogenesis Holdings Inc.
| ORGO | Common | 11,728,063 | 1,875,000 | 38,937,169,000 | 17,950,145,000 | 4.33 | 8.93 |
Hist
| 06/30/2023 |
|
HUMANA INC
| HUM | Common | 62,750 | 39,000 | 28,057,408,000 | 16,527,733,000 | 3.12 | |
Hist
| 06/30/2023 |
|
Vaxcyte, Inc.
| PCVX | Common | 571,250 | 191,000 | 28,528,225,000 | 14,276,455,000 | 3.17 | 0.61 |
Hist
| 06/30/2023 |
|
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
| CRL | Common | 209,496 | 53,400 | 44,046,534,000 | 12,543,239,000 | 4.90 | 0.41 |
Hist
| 06/30/2023 |
|
Beauty Health Co
| SKIN | COMMON STOCK | 2,481,789 | 1,391,837 | 20,772,574,000 | 7,006,480,000 | 2.31 | |
Hist
| 06/30/2023 |
|
CVS HEALTH Corp
| CVS | Common | 355,054 | 111,500 | 24,544,883,000 | 6,446,385,000 | 2.73 | 0.03 |
Hist
| 06/30/2023 |
|
Krystal Biotech, Inc.
| KRYS | Common | 110,192 | 25,013 | 12,936,541,000 | 6,117,110,000 | 1.44 | 0.43 |
Hist
| 06/30/2023 |
|
ANGIODYNAMICS INC
| ANGO | Common | 768,500 | 543,500 | 8,015,455,000 | 5,688,955,000 | 0.89 | 1.96 |
Hist
| 06/30/2023 |
|
TransMedics Group, Inc.
| TMDX | Common | 74,200 | 55,200 | 6,231,316,000 | 4,792,446,000 | 0.69 | 0.23 |
Hist
| 06/30/2023 |
|
Inhibrx, Inc.
| INBX | Common | 473,183 | 35,181 | 12,283,831,000 | 4,018,733,000 | 1.37 | 1.08 |
Hist
| 06/30/2023 |
|
Celcuity Inc.
| CELC | COM | 1,923,283 | 235,350 | 21,117,647,000 | 3,816,334,000 | 2.35 | 8.76 |
Hist
| 06/30/2023 |
|
Pharvaris N.V.
| PHVS | Common | 391,900 | 55,000 | 5,933,366,000 | 3,219,636,000 | 0.66 | 1.16 |
Hist
| 06/30/2023 |
|
NovoCure Ltd
| NVCR | Common | 245,100 | 115,100 | 10,171,650,000 | 2,353,450,000 | 1.13 | 0.23 |
Hist
| 06/30/2023 |
|
RIGEL PHARMACEUTICALS INC
| RIGL | Common | 14,178,015 | 1,375,000 | 18,289,639,000 | 1,389,659,000 | 2.03 | 8.16 |
Hist
| 06/30/2023 |
|
Amylyx Pharmaceuticals, Inc.
| AMLX | Common | 120,000 | 56,786 | 2,588,400,000 | 733,701,000 | 0.29 | 0.18 |
Hist
| 06/30/2023 |
|
Y-mAbs Therapeutics, Inc.
| YMAB | Common | 157,182 | 70,000 | 1,067,266,000 | 630,484,000 | 0.12 | 0.36 |
Hist
| 06/30/2023 |
|
Axsome Therapeutics, Inc.
| AXSM | COM | 24,900 | 4,200 | 1,789,314,000 | 512,538,000 | 0.20 | |
Hist
| 06/30/2023 |
|
Theratechnologies Inc.
| THERF | Common | 9,325,511 | 235,000 | 7,845,077,000 | 481,763,000 | 0.87 | |
Hist
| 06/30/2023 |
|
C4 Therapeutics, Inc.
| CCCC | Common | 2,692,020 | 305,000 | 7,403,055,000 | -92,188,000 | 0.82 | 5.49 |
Hist
| 06/30/2023 |
|
NeuroPace Inc
| NPCE | Common | 2,466,214 | 37,500 | 11,073,301,000 | -195,932,000 | 1.23 | 9.71 |
Hist
| 06/30/2023 |
|
Axogen, Inc.
| AXGN | Common | 1,789,998 | 10,000 | 16,342,682,000 | -478,299,000 | 1.82 | 4.18 |
Hist
| 06/30/2023 |
|
ESSA Pharma Inc.
| EPIX | COM NEW | 4,202,094 | 56,977 | 11,345,654,000 | -965,343,000 | 1.26 | 9.53 |
Hist
| 06/30/2023 |
|
Jasper Therapeutics, Inc.
| JSPR | Common | 7,775,980 | 321,000 | 10,653,093,000 | -2,840,421,000 | 1.18 | 7.11 |
Hist
| 06/30/2023 |
|
EDAP TMS SA
| EDAP | SPONSORED ADR | 5,474,222 | 162,000 | 50,472,327,000 | -8,333,971,000 | 5.61 | |
Hist
| 06/30/2023 |
|
|
|
|